Detection in serum of antilymphocyte-globulin administered in form of eye-drops.
Rosette inhibition tests indicated that similarly as in previous animal experiments, anti-human lymphocyte horse globulin (AHLG) administered in the form of eye-drops entered the systemic blood circulation in man. In the eye into which the AHLG is administered, it is expected to exert a local immunosuppressive effect.
D000328:Adult; D000368:Aged; D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D005123:Eye / Q000276:immunology; D006736:Horses; D006801:Humans; D007104:Immune Adherence Reaction; D008297:Male; D009883:Ophthalmic Solutions / Q000494:pharmacology*
D000961:Antilymphocyte Serum; D009883:Ophthalmic Solutions